Old Web
English
Sign In
Acemap
>
authorDetail
>
Hiska van der Weide
Hiska van der Weide
Maastricht University
Performance status
Medicine
Radiology
Lung cancer
Radiation therapy
3
Papers
172
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Development and External Validation of Prognostic Model for 2-Year Survival of Non–Small-Cell Lung Cancer Patients Treated With Chemoradiotherapy
2009
International Journal of Radiation Oncology Biology Physics
Cary Dehing-Oberije
Shipeng Yu
Dirk De Ruysscher
Sabine Meersschout
Karen Van Beek
Yolande Lievens
Jan P. van Meerbeeck
Wilfried De Neve
Bharat Rao
Hiska van der Weide
Philippe Lambin
Show All
Source
Cite
Save
Citations (77)
Tumor Volume Combined With Number of Positive Lymph Node Stations Is a More Important Prognostic Factor Than TNM Stage for Survival of Non–Small-Cell Lung Cancer Patients Treated With (Chemo)radiotherapy
2008
International Journal of Radiation Oncology Biology Physics
Cary Dehing-Oberije
Dirk De Ruysscher
Hiska van der Weide
Monique Hochstenbag
Gerben Bootsma
Wiel Geraedts
Cordula Pitz
Jean Simons
Jaap Teule
Ali Rahmy
Paul W. L. Thimister
Harald Steck
Philippe Lambin
Show All
Source
Cite
Save
Citations (95)
A2-03: The combination of total tumor volume, number of positive lymph node stations on PET, gender, performance status and radiation dose is the best predictor for survival in patients with inoperable NSCLC, stage I-IIIB, treated with (chemo)radiation
2007
Journal of Thoracic Oncology
Cary Dehing-Oberije
Dirk De Ruysscher
Hiska van der Weide
Monique Hochstenbag
Wiel Geraedts
Cordula Pitz
Jean Simons
Gerben Bootsma
Harald Steck
Philippe Lambin
Show All
Source
Cite
Save
Citations (0)
1